Eye Patch Therapy for Central Serous Retinopathy (CSR)
| Status: | Recruiting |
|---|---|
| Conditions: | Ocular |
| Therapuetic Areas: | Ophthalmology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 7/11/2015 |
| Start Date: | November 2012 |
| Contact: | Sam Pistorius, COA CCRP |
| Email: | pistoriuss@vision.wustl.edu |
| Phone: | 314-747-5832 |
Eye Patching as a Potential Treatment Modality for and a Possible Etiological Insight on Central Serous Retinopathy
First, this study will investigate the viability of 24-hour eye patching as a potential
treatment modality for CSR. Second, this study will assess a potential physiologic
explanation for CSR, namely if inhibition of photic stimulation of the diseased retina will
aid in ameliorating disease severity and disease duration.
treatment modality for CSR. Second, this study will assess a potential physiologic
explanation for CSR, namely if inhibition of photic stimulation of the diseased retina will
aid in ameliorating disease severity and disease duration.
Inclusion Criteria:
- Adults 18 years of age and older
- Both males and females
- Patients diagnosed with active central serous retinopathy
- Patients who are willing to use an eye patch in the affected eye for 24 hours
- Patients who are able to make the follow up appointments as required by the study
Exclusion Criteria:
- Individuals under 18 years of age
- Patients with vision less than 20/40 in the unaffected eye.
- Patients who are not able to undergo mfERG testing in a realiable manner.
We found this trial at
1
site
Click here to add this to my saved trials
